image: From left, Professor Kim Jong Bum, Lee Hyun Ah, and Nam Dong Gyu. l Image credit: Professor Jeong Beom Kim
look more
Credit: UNIST
Sapine Therapeutics Inc.is a UNIST-based biotechnology venture founded by Professor Jeong Beom Kim of UNIST’s School of Life Sciences, which recently 2022 Ulsan Startup Festawas held on November 30, 2022.
This award is directly related to his recent R&D efforts to discover promising treatments for spinal cord injury (SCI) patients, and as a result, contributes to the development of Korean society. Sapine Therapeutics Inc.
Starting with the screening of the opening video with the theme of “Engraving Entrepreneurial Spirit”, the event was held in order of the opening performance, award ceremony, and exhibition hall tour.At the award ceremony, Founder Professor Kim Jong Bum SuPine Therapeutics Inc., received an award from the Small and Medium Enterprise Agency, and Kim Min-ki, CEO of Cheongmyeong Advanced Materials Co., Ltd., received an award for achievement in establishment.
A new spinal cord treatment developed by Sapine Therapeutics Inc. has demonstrated superior therapeutic efficacy in animal models of SCI, has advanced Good Manufacturing Practices (GMP) for conducting clinical trials, and has received approval from the Ministry of Food and Drug Safety (MFDS) and the U.S. Food and Drug Administration We are actively implementing licensing procedures to and the Drug Administration (FDA).
Professor Kim said, “I am very honored to receive this prestigious award. I would like to thank UNIST and everyone who has supported me from the moment I started my own business.” “We will do our best to translate research results into actual clinical practice,” he adds.
Disclaimer: AAAS and EurekAlert! EurekAlert! is not responsible for the accuracy of news releases posted. Use of information by contributors or via the EurekAlert system.
